Clinical trials
Bipolar Disorder I or II clinical trials
Below are recruiting bipolar disorder i or ii clinical trials, each written for real people, not researchers. We’re tracking 2,351 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07527039RecruitingPhase 4
Nerve Block for Pain Relief During Breast Reduction Surgery
This study tests a special numbing technique (pectoral block) to help control pain after breast reduction surgery in women with very large breasts causing symptoms like neck, shoulder, or back pain. The goal is to see if this nerve block reduces pain better than standard pain control methods.
Roanoke, VirginiaAges 18–75 - NCT07530445RecruitingPhase 2
Immunotherapy plus chemotherapy for advanced biliary tract cancer
This study tests a combination of two immunotherapy drugs (iparomlimab and tuvonralimab) plus chemotherapy and a targeted drug (lenvatinib) for biliary tract cancer that has spread or cannot be surgically removed. The goal is to slow cancer growth in patients whose cancer has progressed after one prior treatment.
GuangzhouAges 18–70 - NCT05344339Recruiting
Compare two stomach reconstruction methods after stomach cancer surgery
This study compares two surgical reconstruction techniques after a distal gastrectomy (removing the lower part of the stomach) for gastric (stomach) cancer. It may help find which method leads to better recovery and outcomes after surgery.
Ho Chi Minh CityAges 18–80 - NCT07521683Enrolling by invitationPhase 2
NS-136 treatment study for schizophrenia relapse
This study tests whether NS-136, a new medication, can help people with schizophrenia who are experiencing a relapse or worsening of symptoms. The study measures how well the medication works and what side effects it causes.
ShanghaiAges 18–65 - NCT07521969Recruiting
Outpatient care after emergency appendix removal surgery
This trial tests whether patients with a specific type of appendix infection (gangrenous appendicitis) can safely recover at home instead of staying in the hospital after surgery. The goal is to see if home-based care with close follow-up visits works as well as traditional hospital stays.
Seville, SevillaAges 14 years+ - NCT07520838Recruiting
Telehealth support for autism evaluation and caregiver coaching
This study tests whether telehealth (video visits) can help families get faster access to autism evaluation and support. A coach will work with you and your child over 12 weeks to help navigate care and teach strategies at home.
Minneapolis, MinnesotaAges 1 year+ - NCT07520760RecruitingPhase 2
Eribulin Plus Anlotinib for HER2-Negative Breast Cancer
This trial tests a combination of two cancer drugs (eribulin and anlotinib) for women whose breast cancer has spread and stopped responding to previous treatments, particularly antibody-drug conjugates. The study aims to see if this combination can help slow or shrink the cancer.
GuangzhouAges 18 years+ - NCT07518160RecruitingPhase 2
JS212 and JS111 for advanced lung cancer with EGFR mutations
This study tests a combination of two new drugs (JS212 and JS111) for advanced non-squamous lung cancer that has an EGFR gene mutation and has progressed despite previous EGFR-targeted therapy. The combination may help control the cancer better than standard treatments.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07510880Recruiting
Home brain stimulation for major depression
This trial tests a home-based brain stimulation device (tDCS) to treat depression. You would use a headset daily for a few weeks, and the study team will check in to make sure it's working safely and effectively.
L'Hospitalet de Llobregat, BarcelonaAges 18–65 - NCT07508306Recruiting
Blue dye sentinel node mapping for early ovarian cancer
This study is testing a blue dye called Patent Blue to see if it can help surgeons find sentinel lymph nodes (the first nodes cancer might spread to) during surgery for early-stage ovarian cancer. The goal is to reduce the need for more extensive lymph node removal, possibly leading to fewer side effects.
La RabtaAges 18 years+ - NCT07507370Recruiting
CARED: A fast new treatment plan for depression
This study tests a quick treatment approach for adults with major depression who have not gotten enough help from at least one antidepressant. It aims to see if a new rapid method can improve mood safely.
Chapel Hill, North CarolinaAges 18–70 - NCT07500714Recruiting
Digital therapy for depression using AI
This study uses a smartphone app and artificial intelligence to deliver a special type of talk therapy for people with moderate to severe depression. It aims to provide personalized care without needing to change your current treatment.
Taichung, TaichungAges 18–75 - NCT07499440RecruitingPhase 2
Testing a new medicine, HB-1, for PTSD
This trial tests an experimental medicine, HB-1, as a potential treatment for PTSD. It is a 8-week study to see if the medicine is safe and if it reduces PTSD symptoms. You must have a stable medication routine and be willing to take the study pill daily.
Deakin, Australian Capital TerritoryAges 18–65 - NCT07506109RecruitingPhase 2
Study of sintilimab, ipilimumab, cetuximab, and dabrafenib for advanced colorectal cancer
This trial tests a combination of four drugs for people with a specific type of advanced colorectal cancer that has a BRAF V600E mutation and is microsatellite stable. The goal is to see if this combination can shrink tumors or slow the cancer's growth.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07506395RecruitingPhase 1
Psilocybin group therapy for PTSD
This study tests if psilocybin-assisted group therapy can help people with moderate to severe PTSD. It is for veterans, first responders, female survivors of sexual violence, or Indigenous individuals.
Albuquerque, New MexicoAges 18–89 - NCT07503496Recruiting
Biobran supplement for breast cancer chemo support
This trial tests if a supplement called Biobran (made from rice bran) can help support people with breast cancer who are receiving chemotherapy. It may reduce side effects or improve treatment tolerance.
TaichungAges 20–65 - NCT04513626RecruitingPhase 2
HIV trial testing doravirine plus raltegravir in adults
This Phase 2 trial studies whether switching to a combination of doravirine and raltegravir can safely maintain control of HIV in adults whose virus is already well suppressed. It may help people who are currently on stable HIV treatment and are not resistant to these specific medicines.
Paris, Île-de-France RegionAges 18 years+ - NCT06769971RecruitingPhase 2
Ivonescimab and cadonilimab plus chemo for extensive-stage small cell lung cancer
This trial tests a combination of two experimental immunotherapy drugs (ivonescimab and cadonilimab) with standard chemotherapy for people with extensive-stage small cell lung cancer who have not had prior treatment. The goal is to see if this combination works better than chemo alone.
Chengdu, SichuanAges 18–75 - NCT06769295RecruitingPhase 2
Study of AK112 plus chemo for advanced lung cancer
This trial tests a new drug, AK112, combined with chemotherapy for people with advanced non-squamous non-small cell lung cancer that has spread to the lining of the lung (malignant pleural effusion). The goal is to see if this combination helps shrink tumors and improve outcomes.
Chengdu, SichuanAges 18–75 - NCT07493317RecruitingPhase 2
Tocilizumab for depression with inflammation
This trial tests a medication called tocilizumab, which targets inflammation, to see if it can improve symptoms of major depression in people with signs of inflammation. You may be eligible if you have depression with a high monocyte count and significant loss of interest or pleasure.
New York, New YorkAges 18–70 - NCT07491146RecruitingPhase 2
Study of HSK55718 for pain after abdominal surgery
This trial tests a new medicine, HSK55718, to see if it safely reduces pain after planned abdominal surgery. It is for adults who have moderate or severe pain after surgery and are otherwise in good health.
Changsha, HunanAges 18 years+ - NCT07490782Recruiting
Nutrition study for college students with depression
This trial tests whether changes in diet can help improve mild to moderate depression in college students. If you are currently getting treatment or are open to it, you may be able to join.
La Jolla, CaliforniaAges 18 years+ - NCT07490353RecruitingPhase 1
Can psilocybin help treat loss of pleasure?
This trial tests if psilocybin, a psychedelic substance, can improve the ability to feel pleasure (anhedonia) in people with depression who are not taking antidepressants. It also includes healthy volunteers as a comparison group.
Vienna, State of ViennaAges 18–55 - NCT07489716RecruitingPhase 2
Study of SHR-1826 for advanced non-small cell lung cancer
This trial tests a new drug, SHR-1826, for people with advanced or metastatic non-small cell lung cancer that has gotten worse after previous treatment. The goal is to see if the drug can help control the cancer.
Jinan, ShandongAges 18–75
Hear when a new Bipolar Disorder I or II trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for bipolar disorder i or ii?
- Yes. Clin2 currently lists 2,351 recruiting bipolar disorder i or ii studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a bipolar disorder i or ii trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a bipolar disorder i or ii trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.